HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
about
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenThe Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsTargeting the intragraft microenvironment and the development of chronic allograft rejectionDesensitization for solid organ and hematopoietic stem cell transplantationMHC class I signaling: new functional perspectives for an old moleculeVascular endothelium as a target of immune response in renal transplant rejectionMonocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Fcγ Receptors in Solid Organ TransplantationAntibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisCharacterization of the endothelial cell cytoskeleton following HLA class I ligationA rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among CaucasiansComplement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questionsCostimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten.The link between major histocompatibility complex antibodies and cell proliferation.Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.Effect of antibodies on endothelium.Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice.Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cellsHLA class I: an unexpected role in integrin β4 signaling in endothelial cellsCD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivoAntibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner.Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.Chronic alloantibody mediated rejection.C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow CrossmatchReport from a consensus conference on the sensitized patient awaiting heart transplantationHLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration.HLA class I antibody-mediated endothelial and smooth muscle cell activation.Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways.Sensitized renal transplant recipients: current protocols and future directions.Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft InjuryProspects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Transplant glomerulopathy: the interaction of HLA antibodies and endothelium
P2860
Q26766411-0EEF9BAA-4DF5-4556-A7D2-652420664BEEQ26774993-4DB0F9A0-8D1B-4795-BA03-7CF4860459A4Q26852762-FA41FD3A-B52A-4161-9BEF-DBB56E47F006Q26863564-6FB503F9-61B6-4891-A5BE-D76DB05E9FC5Q27000194-E0A249C8-DA53-4A0C-B487-FEF752AC46F6Q27024077-37C67CE0-72D2-4D12-B220-9AD2E5DEB386Q27314948-8E504DC8-FF1B-4589-B0DB-25B94D0828F8Q28076012-874B0A6C-56B8-4263-8D38-638F4A9A6173Q28076193-D44DF8C1-1CF9-4D83-BAA4-781A5B85AF9AQ28084366-35E079F9-B637-4B07-8BD0-B0876D81C1E8Q28478778-3DCED3A2-3099-4222-AE6B-C7E233C1C3E5Q33665945-9789FC59-612D-4392-A3C0-975E35EAE68FQ33829159-81D6531C-31C1-4A2C-B216-7269C8A6429DQ34289043-92F9665C-BF84-4132-93C4-FEF28042CDCBQ34416068-D5973B3C-E0FE-4354-874A-6DE521683F76Q35223952-D95DC8EC-3277-46CC-A129-2E76EC152AD1Q35469913-ED80E90B-C3DD-4F66-B85F-5CCAE1732483Q35547335-E8A75177-80F5-4BB3-B471-FA9BEBE44161Q35655757-D67897BD-3460-4227-84D0-F61EA1576FE6Q35874401-BCBC177D-B85D-4C3E-9897-F424504DAD4DQ36312784-770BD5C0-C1CB-43E6-AD5C-86260A318067Q36360674-83BC0A1C-95F8-4461-9420-754AC29EF06EQ36393439-7EDB47A4-8AA6-4082-AFAE-8C8FC418DF2BQ36584507-837C8DF3-845F-42BA-BE27-C9EB23CAF3AFQ36584512-5D1F06BA-C61E-4EB0-B887-305D78DDCCC9Q37058050-209BD445-24FA-48E4-BEB0-D179265D58C0Q37263143-F20DC496-5EAC-4FBF-A9DB-5FF3D1DFCB28Q37414657-8A312D0E-F4E1-4492-8D45-707D8448F0F5Q37426000-AC8C7E1D-2885-42AF-AA02-E73D81B7E1ABQ37430871-106C0013-5D77-4A2C-922F-790594990BE2Q37469109-1A2D81A7-A9FB-48F6-A03E-0CB9A0A4FAC9Q37528715-A37363D4-8D26-480E-B093-F99E4928E4FFQ37596125-1408CB7A-5555-4524-98D0-2A6C9D8A5126Q37710374-20EA3FE5-9257-4F60-B1C5-291EBC3AEEC2Q37720377-E7043D1F-4BB6-4D46-B7E9-F9FE3CC1D0EDQ37760379-D8CFB6BB-FDEB-425C-BC4A-ECC77A42A253Q38025804-B1ADC28D-76B3-4E9E-A143-FB8F411A5890Q38032621-E87249F6-BDC6-49D1-A908-382B5A11687DQ38123309-6EFCD940-FA09-4754-9E00-A62DF111F01AQ38205229-3EB15235-97A7-47D0-B1A1-8E29EF11751F
P2860
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@en
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@nl
type
label
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@en
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@nl
prefLabel
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@en
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@nl
P2093
P1476
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
@en
P2093
Elaine F Reed
Enquire Rozengurt
Peter T Jindra
Yi-Ping Jin
P304
P356
10.4049/JIMMUNOL.180.4.2357
P407
P577
2008-02-01T00:00:00Z